Merck & Company News - July 17, 2026

Merck Reportedly Among Bidders for Cancer Diagnostics Firm Personalis

Cancer diagnostics company Personalis (PSNL) explores a sale. The company received takeover interest from Merck (MRK) and at least two other bidders....

🟢 Merck is trading 3.1% up today after FDA approval of oral cholesterol drug Lipfendra

Merck is trading 3.1% up at $131.54 after winning FDA approval for Lipfendra, the first once-daily oral PCSK9 inhibitor for lowering LDL cholesterol in...